CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing prevalence of cardiovascular diseases
4.1.2. The huge gap between the demand and supply of donor's hearts
4.1.3. Regulatory approval of several new and advanced heart pump devices
4.2. Market Restraints & Challenges
4.2.1. The high cost of heart-pumping devices
4.2.2. Limited reimbursement for heart pump devices for destination therapy
4.3. Market Opportunities
4.3.1. Growth potential offered by emerging economies
CHAPTER 5. GLOBAL HEART PUMP DEVICES MARKET – BY PRODUCT
5.1. Ventricular Assist Devices
5.1.1. Left Ventricular Assist Devices
5.1.2. Right Ventricular Assist Devices
5.1.3. Percutaneous Ventricular Assist Devices
5.1.4. Bi-Ventricular Assist Devices
5.2. Intra-Aortic Balloon Pumps
5.3. Total Artificial Heart
CHAPTER 6. GLOBAL HEART PUMP DEVICES MARKET – BY TYPE
6.1. Implantable Heart Pump Devices
6.2. Extracorporeal Heart Pump Devices
CHAPTER 7. GLOBAL HEART PUMP DEVICES MARKET – BY THERAPY
7.1. Bridge-To-Candidacy (BTC)
7.2. Bridge-To-Transplant (BTT)
7.3. Destination Therapy (DT)
7.4. Others
CHAPTER 8. GLOBAL HEART PUMP DEVICES MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL HEART PUMP DEVICES MARKET - COMPANY PROFILES
9.1. Abbott Laboratories
9.2. Getinge AB
9.3. Medtronic PLC
9.4. Abiomed, Inc.
9.5. Syncardia Systems
9.6. Terumo Medical Corporation
9.7. Reliantheart Inc.
9.8. Teleflex Incorporated
9.9. Berlin Heart GmbH
9.10. Cardiacassist, Inc.
9.11. Jarvik Heart Inc.
9.12. Fresenius Medical Care
CHAPTER 10. GLOBAL HEART PUMP DEVICES MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
